Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M546Revenue $M165Net Margin (%)-40.4Altman Z-Score0.0
Enterprise Value $M313EPS $-0.4Operating Margin %-35.0Piotroski F-Score5
P/E(ttm)--Beneish M-Score2.2Pre-tax Margin (%)-40.3Higher ROA y-yY
Price/Book4.410-y EBITDA Growth Rate %--Quick Ratio5.4Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %-24.3Current Ratio5.4Lower Leverage y-yY
Price/Free Cash Flow9.6y-y EBITDA Growth Rate %--ROA % (ttm)-24.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-38.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M49.0ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 10.81-65%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 10.81-73%Reduce 46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 10.81-57%New holding75,000
INFIFirst Eagle Investment 2012-06-30 Sold Out -0.01%$11.71 - $13.76
($12.78)
$ 10.81-15%Sold Out0
INFIFirst Eagle Investment 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 10.8136%Reduce 54.94%180,000
INFIFirst Eagle Investment 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 10.8137%Reduce 25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 10.8166%Sold Out0
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 10.8176%Reduce 63.91%7,415
INFIFirst Eagle Investment 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 10.8176%Add 60.34%585,437
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 10.8196%Reduce 25.39%20,545
INFIFirst Eagle Investment 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 10.8196%Add 29.72%365,123
INFIFirst Eagle Investment 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 10.8164%Add 566.95%281,460
INFIFirst Eagle Investment 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 10.8183%Add 451.43%42,201
INFIFirst Eagle Investment 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 10.8155%New holding7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 10.8137%New holding28,437
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-1.1 view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-1.46 view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-15.61 view
Perkins Adelene QPresident & CEO 2015-05-14Sell10,000$12.18-11.25 view
Perkins Adelene QPresident & CEO 2015-03-16Sell20,000$16-32.44 view
Perkins Adelene QPresident & CEO 2015-03-05Sell25,000$16.5-34.48 view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-27.11 view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-27.11 view
Palombella Vito J.Chief Scientific Officer 2014-12-15Sell4,737$16.32-33.76 view
Palombella Vito J.Chief Scientific Officer 2014-11-26Sell4,736$15-27.93 view

Quarterly/Annual Reports about INFI:

News about INFI:

Articles On GuruFocus.com
own Mar 02 2015 
comment on INFI Mar 02 2013 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
Edited Transcript of INFI presentation 7-May-15 5:30pm GMT Jun 18 2015
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 16 2015
Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Naïve Patients... May 31 2015
Infinity to Participate in Three Investor Conferences in June May 27 2015
Infinity to Participate in Three Investor Conferences in June May 27 2015
Infinity Reports Preclinical Data for Duvelisib Demonstrating Synergy with Standard-of-Care... May 26 2015
Infinity Reports Preclinical Data for Duvelisib Demonstrating Synergy with Standard-of-Care... May 26 2015
Infinity Announces New Data for Duvelisib to Be Presented at the 2015 American Society of Clinical... May 13 2015
Infinity Announces New Data for Duvelisib to Be Presented at the 2015 American Society of Clinical... May 13 2015
On the move: New hires and appointments in the local life sciences industry May 11 2015
Infinity Pharmaceuticals Hits Its Limit May 08 2015
Street Talk: Bullish Amazon call May 07 2015
Coverage initiated on Infinity Pharmaceutical by Deutsche Bank May 07 2015
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements... May 07 2015
Infinity Reports First Quarter 2015 Financial Results and Recent Corporate Developments May 06 2015
Infinity Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today May 06 2015
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 06 2015
Infinity reports 1Q loss May 06 2015
Infinity reports 1Q loss May 06 2015
INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 06 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK